The advertisement promotes the use of specific codes for reimbursement related to the prescription of VYVGART and VYVGART Hytrulo, highlighting its status as a new biosimilar treatment.
Creative Information
| CID: | 0e1e81d6-afd0-415d-b956-00d7d79c2e5d |
| CRID: | 82_5970-755312 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 320x50 |
| Bid: | $0.34 |
| Timestamp: | 11/2/2025, 1:21:17 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/11/2025, 11:00:51 PM | 7.05s | |
| adomain_analysis | success | 11/12/2025, 12:27:17 AM | 2.90s | |
| adomain_capture | success | 11/12/2025, 12:26:57 AM | 0.09s | |
| ad_render | success | 11/11/2025, 11:00:44 PM | 24.00s | |
| brand_mapping | success | 11/12/2025, 12:26:58 AM | 1.32s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 320x50 | ||||||||||||||||||||||
| Data Transferred: | 599.36 KB | ||||||||||||||||||||||
| Render Time: | 8.29 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 599.40 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
